Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
TFX · against 201 other Healthcare companies of similar size
Ranked #155 of 202 · scores higher than 23% of peers
Bars: peers in each 10-point band of the growth score24 peers with a growth score of 30–39, including TFX · Click a bar to see the companies
Mainly because of its 3-year revenue growth, which is weaker than most Healthcare peers.
| Metric | TFX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 201 reported | 17.2% | 8.1% | 71% | 33% | |
| Earnings per share growthHigher is better · 139 reported | Not reported | 9.8% | — | — | 33% |
| 3-year revenue growthHigher is better · 194 reported | -10.6% | 9.1% | 7% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 2 | 8.8B USD | 99 | 31 | |
| 3 | 37.3B HKD (≈$4.8B) | 98 | 90 | |
| 3 | 3.8B USD | 98 | 71 | |
| 3 | 9.3B USD | 98 | 64 | |
| 151 | 170.4B THB (≈$4.8B) | 37 | 70 | |
| 151 | 10.8B USD | 37 | 41 | |
| 151 | 8.5B USD | 37 | 28 | |
| 155 | 3.0B USD | 36 | 35 | |
| 155 | 5.9B USD | 36 | 39 | |
| 157 | 28.4B CNY (≈$4.0B) | 35 | 62 | |
| 158 | 1.42T JPY (≈$9.6B) | 34 | 50 | |
| 158 | 576.5B JPY (≈$3.9B) | 34 | 67 | |
| 160 | 26.6B CNY (≈$3.7B) | 33 | 67 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score